BRAINLIFE.ORG

Current Neuro-Oncology

Volume 1 Supplement 2
31 December 1999

Home > Publications > Current Neuro-Oncology > Volume 1, Year 1999 > Supplement 2, 31 December

Literature selection: 1990 – 1994

▫Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B.
A randomized trial of surgery in the treatment of single metastases to the brain.
N Engl J Med. 1990 Feb 22;322(8):494-500. doi: 10.1056/NEJM199002223220802. PMID: 2405271. Interventional study. ˍ

▫Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, et al.
The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
J Neurosurg. 1990 Apr;72(4):572-82. doi: 10.3171/jns.1990.72.4.0572. PMID: 2319316 . Interventional study. ˍ

▫Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P.
Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
Eur J Cancer. 1990 Apr;26(4):464-9. doi: 10.1016/0277-5379(90)90017-N. PMID: 2141512. Interventional study. ˍ

▫Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD.
Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Cancer Res. 1990 Apr 15;50(8):2347-50. PMID: 2180567. Laboratory investigation. ˍ
Erratum in: Cancer Res. 1990 Jun 15;50(12):3809. Correction. ˍ

▫Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ.
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
Proc Natl Acad Sci USA. 1990 Aug 1;87(16):6166-70. doi: 10.1073/pnas.87.16.6166. PMID: 2143581. Laboratory investigation. ˍ

▫Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M.
Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues.
Proc Natl Acad Sci USA. 1990 Aug 1;87(15):5710-4. doi: 10.1073/pnas.87.15.5710. PMID: 2377607. Laboratory investigation. ˍ

▫Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, et al.
Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.
J Neurosurg. 1991 Mar;74(3):433-40. doi: 10.3171/jns.1991.74.3.0433. PMID: 1847194. Observational study. ˍ

▫Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL.
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
J Neurosurg. 1991 Jun;74(6):861-6. doi: 10.3171/jns.1991.74.6.0861. PMID: 2033444. Interventional study. ˍ

Kawase T, Shiobara R, Toya S.
Anterior transpetrosal-transtentorial approach for sphenopetroclival meningiomas: surgical method and results in 10 patients.
Neurosurgery. 1991 Jun 1;28(6):869-75. doi: 10.1227/00006123-199106000-00014. PMID: 2067611. Observational study. ˍ

▫Bleehen NM, Stenning SP.
A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
Br J Cancer. 1991 Oct 1;64(4):769-74. doi: 10.1038/bjc.1991.396. PMID: 1654987. Interventional study. ˍ

▫Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM.
The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.
Br J Cancer. 1991 Nov 1;64(5):959-61. doi: 10.1038/bjc.1991.435. PMID: 1931625. Observational study. ˍ

▫Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Cancer Res. 1992 Feb 1;52(3):674-9. PMID: 1346255. Laboratory investigation. ˍ

*Newlands ES, Blackledge GR, Slack JA, Rustin GJ, Smith DB, Stuart NS, Quarterman CP, Hoffman R, Stevens MF, Brampton MH, Gibson AC.
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).
Br J Cancer. 1992 Feb 1;65(2):287-91. doi: 10.1038/bjc.1992.57. PMID: 1739631. Interventional study. ˍ

▫Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B.
Clonal expansion of p53 mutant cells is associated with brain tumour progression.
Nature. 1992 Feb 27;355(6363):846-7. doi: 10.1038/355846a0. PMID: 1311419. Laboratory investigation. ˍ

▫Recht LD, Lew R, Smith TW.
Suspected low-grade glioma: is deferring treatment safe?
Ann Neurol. 1992 Apr;31(4):431-6. doi: 10.1002/ana.410310413. PMID: 1586143. Observational study. ˍ

▫Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B.
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Proc Natl Acad Sci USA. 1992 Apr 1;89(7):2965-9. doi: 10.1073/pnas.89.7.2965. PMID: 1557402. Laboratory investigation. ˍ

Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM.
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.
Science. 1992 Jun 12;256(5063):1550-2. doi: 10.1126/science.1317968. PMID: 1317968. Laboratory investigation. ˍ

▫Miralbell R, Linggood RM, de la Monte S, Convery K, Munzenrider JE, Mirimanoff RO.
The role of radiotherapy in the treatment of subtotally resected benign meningiomas.
J Neurooncol. 1992 Jun;13(2):157-64. doi: 10.1007/BF00172765. PMID: 1432033. Observational study. ˍ

▫Kallio M, Sankila R, Hakulinen T, Jääskeläinen J.
Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma.
Neurosurgery. 1992 Jul 1;31(1):2-12. doi: 10.1097/00006123-199207000-00002. PMID: 1641106. Observational study. ˍ

▫Maier H, Ofner D, Hittmair A, Kitz K, Budka H.
Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.
J Neurosurg. 1992 Oct;77(4):616-23. doi: 10.3171/jns.1992.77.4.0616. PMID: 1527622. Observational study. ˍ

▫Plate KH, Breier G, Weich HA, Risau W.
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Nature. 1992 Oct 29;359(6398):845-8. doi: 10.1038/359845a0. PMID: 1279432. Laboratory investigation. ˍ

Shweiki D, Itin A, Soffer D, Keshet E.
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
Nature. 1992 Oct 29;359(6398):843-5. doi: 10.1038/359843a0. PMID: 1279431. Laboratory investigation. ˍ

▫Bricolo AP, Turazzi S, Talacchi A, Cristofori L.
Microsurgical removal of petroclival meningiomas: a report of 33 patients.
Neurosurgery. 1992 Nov 1;31(5):813-28. doi: 10.1227/00006123-199211000-00001. PMID: 1436406. Observational study. ˍ

▫Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, et al.
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
J Natl Cancer Inst. 1993 May 5;85(9):704-10. doi: 10.1093/jnci/85.9.704. PMID: 8478956. Observational study. ˍ

▫Duma CM, Lunsford LD, Kondziolka D, Harsh GR 4th, Flickinger JC.
Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery.
Neurosurgery. 1993 May 1;32(5):699-704. doi: 10.1227/00006123-199305000-00001. PMID: 8492844. Observational study. ˍ

Baer JC, Freeman AA, Newlands ES, Watson AJ, Rafferty JA, Margison GP.
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
Br J Cancer. 1993 Jun 1;67(6):1299-302. doi: 10.1038/bjc.1993.241. PMID: 8512814. Laboratory investigation. ˍ

▫Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA.
Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection.
J Neurosurg. 1993 Jul;79(1):62-9. doi: 10.3171/jns.1993.79.1.0062. PMID: 8315470. Observational study. ˍ

▫Shibamoto Y, Kitakabu Y, Takahashi M, Yamashita J, Oda Y, Kikuchi H, Abe M.
Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables.
Cancer. 1993 Jul 1;72(1):190-5. doi: 10.1002/1097-0142(19930701)72:1<190::aid-cncr2820720134>3.0.co;2-y. PMID: 8508405. Observational study. ˍ

▫Murphy M, Pykett MJ, Harnish P, Zang KD, George DL.
Identification and characterization of genes differentially expressed in meningiomas.
Cell Growth Differ. 1993 Sep;4(9):715-22. PMID: 7694637. Laboratory investigation. ˍ

▫Hoffman HJ, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, Piatt JH Jr.
Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review.
Neurosurgery. 1993 Dec;33(6):964-71. doi: 10.1227/00006123-199312000-00002. PMID: 8134009. Observational study˰ ˍ

▫Mahmood A, Caccamo DV, Tomecek FJ, Malik GM.
Atypical and malignant meningiomas: a clinicopathological review.
Neurosurgery. 1993 Dec 1;33(6):955-63. doi: 10.1097/00006123-199312000-00001. PMID: 8134008. Observational study. ˍ

▫Goldsmith BJ, Wara WM, Wilson CB, Larson DA.
Postoperative irradiation for subtotally resected meningiomas. A Observational study of 140 patients treated from 1967 to 1990.
J Neurosurg. 1994 Feb;80(2):195-201. doi: 10.3171/jns.1994.80.2.0195. PMID: 8283256. Observational study. ˍ
Erratum in: J Neurosurg 1994 Apr;80(4):777. doi: 10.3171/jns.1994.80.4.0777. Correction. ˍ

▫Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP, et al.
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Nat Genet. 1994 Feb 1;6(2):180-4. doi: 10.1038/ng0294-180. PMID: 8162072. Laboratory investigation. ˍ

▫Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A.
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
Nature. 1994 Feb 10;367(6463):576-9. doi: 10.1038/367576a0. PMID: 8107827. Laboratory investigation. ˍ

▫Pollack IF, Pang D, Albright AL.
The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors.
J Neurosurg. 1994 Apr;80(4):681-8. doi: 10.3171/jns.1994.80.4.0681. PMID: 8151347. Observational study. ˍ

▫Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, et al.
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Radiology. 1994 Apr 1;191(1):41-51. doi: 10.1148/radiology.191.1.8134596. PMID: 8134596. Observational study. ˍ

Plowman J, Waud WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR.
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Cancer Res. 1994 Jul 15;54(14):3793-9. PMID: 8033099. Laboratory investigation. ˍ

▫DeMonte F, Smith HK, al-Mefty O.
Outcome of aggressive removal of cavernous sinus meningiomas.
J Neurosurg. 1994 Aug;81(2):245-51. doi: 10.3171/jns.1994.81.2.0245. PMID: 8027808. Observational study. ˍ

▫Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ.
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Proc Natl Acad Sci USA. 1994 Aug 2;91(16):7727-31. doi: 10.1073/pnas.91.16.7727. PMID: 8052651. Laboratory investigation. ˍ

▫Berger MS, Deliganis AV, Dobbins J, Keles GE.
The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.
Cancer. 1994 Sep 15;74(6):1784-91. doi: 10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d. PMID: 8082081. Observational study. ˍ

▫Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, et al.
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
J Neurosurg. 1994 Nov;81(5):690-8. doi: 10.3171/jns.1994.81.5.0690. PMID: 7931615. Observational study. ˍ

▫Celli P, Nofrone I, Palma L, Cantore G, Fortuna A.
Cerebral oligodendroglioma: prognostic factors and life history.
Neurosurgery. 1994 Dec 1;35(6):1018-34. doi: 10.1227/00006123-199412000-00003. PMID: 7885546. Observational study. ˍ

Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL.
Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.
Proc Natl Acad Sci USA. 1994 Dec 20;91(26):12867-71. doi: 10.1073/pnas.91.26.12867. PMID: 7809137. Laboratory investigation. ˍ